Claudia Kimie Suemoto

Claudia Kimie Suemoto

Auto-generated profile, based on publicly available information

Claudia Kimie Suemoto

Departamento de Geriatria, Universidade de São Paulo, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2021 in Current Protein & Peptide Science
Verified
Journal Article
Closed access
PDF file
ETEliana Toscano
Eliana Toscano
NRNatalia P. Rocha
Natalia P. Rocha
BLBeatriz N. A. Lopes
Beatriz N. A. Lopes
CSClaudia K. Suemoto
Claudia K. Suemoto
Antonio TeixeiraAntonio Teixeira
Antonio Teixeira
Background: Alzheimer’s disease (AD) is the main cause of dementia worldwide. The definitive diagnosis of AD is clinicopathological and based on the identification of cerebral deposition of Amyloid β (Aβ) plaques and neurofibrillary tangles. However, the link between amyloid cascade and depositions of phosphorylated tau (p-tau) is still missing. In this scenario, inflammasomes might play a relevant role. Experimental models of AD have suggested that Aβ accumulation induces, through microglia, activation of the NLRP3 inflammasome. This activation contributes to the dissemination of Aβ and p-tau, as well as to hyperphosphorylation of tau. Also, in experimental models, NLPR1 promoted neuronal pyroptosis. There are neither comprehensive neuropathologic characterization nor clinicopathologic studies evaluating the NLRP1 and NLRP3 inflammasomes in subjects with AD. Objective: The current mini-review aims to summarize recent and promising findings on the role of NLRP1 and NLRP3 signaling in the pathophysiology of AD. We also sought to highlight the knowledge gap in patients with AD, mainly the lack of clinicopathologic studies on the interaction among inflammasomes, Aβ/tau pathology, and cognitive decline.

15 November 2020 in Alcohol, Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
DSDaniele P. Santos‐Bezerra
Daniele P. Santos‐Bezerra
ACAna Mercedes Cavaleiro
Ana Mercedes Cavaleiro
ASAritania Santos
Aritania Santos
CSClaudia Kimie Suemoto
Claudia Kimie Suemoto
CPCarlos Augusto Pasqualucci
Carlos Augusto Pasqualucci
MCMaria Lucia Correa-Giannella
Maria Lucia Correa-Giannella

28 June 2018 in Neural Plasticity
Verified
Journal Article
Open access
PDF file
DVDarine Villela
Darine Villela
CSClaudia K. Suemoto
Claudia K. Suemoto
RLRenata Leite
Renata Leite
CPCarlos Augusto Pasqualucci
Carlos Augusto Pasqualucci
LGLea T. Grinberg
Lea T. Grinberg
CRCarla Rosenberg
Carla Rosenberg
Aging is a complex process strongly determined by genetics. Previous reports have shown that the genome of neuronal cells displays somatic genomic mosaicism including DNA copy number variations (CNVs). CNVs represent a significant source of genetic variation in the human genome and have been implicated in several disorders and complex traits, representing a potential mechanism that contributes to neuronal diversity and the etiology of several neurological diseases and provides new insights into the normal, complex functions of the brain. Nonetheless, the features of somatic CNV mosaicism in nondiseased elderly brains have not been investigated. In the present study, we demonstrate a highly significant increase in the number of CNVs in nondiseased elderly brains compared to the blood. In two neural tissues isolated from paired postmortem samples (same individuals), we found a significant increase in the frequency of deletions in both brain areas, namely, the frontal cortex and cerebellum. Also, deletions were found to be significantly larger when present only in the cerebellum. The sizes of the variants described here were in the 150–760 kb range, and importantly, nearly all of them were present in the Database of Genomic Variants (common variants). Nearly all evidence of genome structural variation in human brains comes from studies detecting changes in single cells which were interpreted as derived from independent, isolated mutational events. The observations based on array-CGH analysis indicate the existence of an extensive clonal mosaicism of CNVs within and between the human brains revealing a different type of variation that had not been previously characterized.

1 March 2021 in Dementia & Neuropsychologia
Verified
Journal Article
Open access
PDF file
CRCaroline Cristiano Real
Caroline Cristiano Real
CSCláudia Kimie Suemoto
Cláudia Kimie Suemoto
KBKarina Henrique Binda
Karina Henrique Binda
LGLea Tenenholz Grinberg
Lea Tenenholz Grinberg
CPCarlos Augusto Pasqualucci
Carlos Augusto Pasqualucci
LBLuiz Roberto de Britto
Luiz Roberto de Britto
Clinical trials of the effects of physical activity have reported improvements in symptoms and quality of life in patients with Parkinson's disease (PD). Additionally, morphological brain changes after exercising were reported in PD animal models. However, these lifestyle-related changes were not evaluated in postmortem brain tissue. Objective: We aimed to evaluate, by immunohistochemistry, astrocytes, tyrosine hydroxylase (TH) and structural proteins expression (neurofilaments and microtubules — MAP2) changes in postmortem brain samples of individuals with Lewy body pathology. Methods: Braak PD stage≥III samples, classified by neuropathology analysis, from The Biobank for Aging Studies were classified into active (n=12) and non-active (n=12) groups, according to physical activity lifestyle, and paired by age, sex and Braak staging. Substantia nigra and basal ganglia were evaluated. Results: Groups were not different in terms of age or gender and had similar PD neuropathological burden (p=1.00). We observed higher TH expression in the active group in the substantia nigra and the basal ganglia (p=0.04). Astrocytes was greater in the non-active subjects in the midbrain (p=0.03) and basal ganglia (p=0.0004). MAP2 levels were higher for non-active participants in the basal ganglia (p=0.003) and similar between groups in the substantia nigra (p=0.46). Neurofilament levels for non-active participants were higher in the substantia nigra (p=0.006) but not in the basal ganglia (p=0.24). Conclusion: Active lifestyle seems to promote positive effects on brain by maintaining dopamine synthesis and structural protein expression in the nigrostriatal system and decrease astrogliosis in subjects with the same PD neuropathology burden.

1 January 2019 in Cadernos de Saude Publica
Verified
Journal Article
Open access
DSDouglas Rene Rocha Silva
Douglas Rene Rocha Silva
CSClaudia Kimie Suemoto
Claudia Kimie Suemoto
NGNelson Gouveia
Nelson Gouveia